Q32

Details:

Details about Q32

Q32 Bio is developing drugs targeting powerful regulators of both the innate and adaptive immune systems with the goal of re-balancing the immune system.

[email protected]

Employees:

Employees at Q32

Shelia Violette

Advisor at Q32

Jennifer Morgan

Scientist at Q32 Bio at Q32

Charles Romano

Vice President Clinical Development at Q32

Hong Wu

Head of Nonclinical Development at Q32

Ivan Mascanfroni

Senior Director, Immunology at Q32

Kelly Fahnoe

Associate Director, Protein Science at Q32

Justin Rogers

Director, Quality Assurance at Q32